A remarkable new study demonstrates that embracing traditional African dietary patterns, even for just two weeks, can ...

This review examined whether switching to a different antipsychotic medicine, as opposed to continuing treatment with the same one, improved people's response rates, alleviated overall and specific ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

As AI transforms mental health care, questions about app efficacy, privacy, and ethical design highlight the need for rigorous validation and oversight.

There is growing recognition that substance use research in the United States has not always been attentive to the ...

A rare policy quirk in Wales offered scientists an accidental natural experiment—and what they found could reshape how we ...

The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients ...

A new multimodal tool combines a large language model with powerful graph-based AI models to efficiently find new, synthesizable molecules with desired properties, based on a user's queries in plain ...

On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global ...

Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.